Detalhe da pesquisa
1.
Efficacy and Safety of Donidalorsen for Hereditary Angioedema.
N Engl J Med
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819395
2.
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.
N Engl J Med
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819658
3.
Inhibition of Prekallikrein for Hereditary Angioedema.
N Engl J Med
; 386(11): 1026-1033, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294812
4.
Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus.
J Allergy Clin Immunol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38670233
5.
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial.
Lancet
; 401(10375): 458-469, 2023 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774155
6.
A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema.
Allergy
; 79(3): 724-734, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38009241
7.
The future of therapeutic options for hereditary angioedema.
Ann Allergy Asthma Immunol
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679158
8.
Hereditary angioedema outcomes in US patients switched from injectable long-term prophylactic medication to oral berotralstat.
Ann Allergy Asthma Immunol
; 132(4): 505-511.e1, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006972
9.
Hereditary angioedema in older adults: Understanding the patient perspective.
Ann Allergy Asthma Immunol
; 132(1): 76-81.e2, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37852604
10.
Long-term lanadelumab treatment improves health-related quality of life in patients with hereditary angioedema.
Ann Allergy Asthma Immunol
; 131(1): 101-108.e3, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37028510
11.
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being.
Allergy Asthma Proc
; 44(2): 115-121, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36872446
12.
Healthcare utilization of patients with hereditary angioedema treated with lanadelumab and subcutaneous C1-inhibitor concentrate.
Allergy Asthma Proc
; 44(4): 275-282, 2023 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37328263
13.
Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study.
Allergy
; 77(3): 979-990, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34287942
14.
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update.
Allergy
; 77(7): 1961-1990, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35006617
15.
Consider Hereditary Angioedema in the Differential Diagnosis for Unexplained Recurring Abdominal Pain.
J Clin Gastroenterol
; 56(9): 740-747, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35960533
16.
Optimization of care for patients with hereditary angioedema living in rural areas.
Ann Allergy Asthma Immunol
; 128(5): 526-533, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34628006
17.
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives.
Allergy Asthma Proc
; 43(5): 397-405, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35820771
18.
Consensus on treatment goals in hereditary angioedema: A global Delphi initiative.
J Allergy Clin Immunol
; 148(6): 1526-1532, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34048855
19.
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.
J Allergy Clin Immunol
; 148(1): 164-172.e9, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098856
20.
Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study.
Allergy
; 76(4): 1188-1198, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33258114